Pharma stocks soar 6% as investors respond to double dose of Good News!

Q: How long will it take to read this news story?

The story "Pharma stocks soar 6% as investors respond to double dose of Good News!" has 612 words across 30 sentences, which will take approximately 3 - 6 minutes for the average person to read.

Q: Which news outlet covered this story?

The story "Pharma stocks soar 6% as investors respond to double dose of Good News!" was covered 8 hours ago by Business Standard, a news publisher based in India.

Q: How trustworthy is 'Business Standard' news outlet?

Business Standard is a fully independent (privately-owned) news outlet established in 1975 that covers mostly business and finance news. The outlet is headquartered in India and publishes an average of 304 news stories per day. It's most recent story was published 2 hours ago.

Q: What do people currently think of this news story?

The sentiment for this story is currently Neutral, indicating that people are not responding positively or negatively to this news.

Q: How do I report this news for inaccuracy?

You can report an inaccurate news publication to us via our contact page. Please also include the news #ID number and the URL to this story.<ul><li>News ID: #22445536</li><li>URL: https://beamstart.com/news/pharma-stocks-soar-6-as-17259568526455</li></ul>

Business Standard Logo Business Standard 8h ago

Pharma stocks soar 6% as investors respond to double dose of Good News! - Business Standard

Quick Summary:

Individually, shares of Laurus Labs rose up to 5.55 per cent at Rs 517.90 per share, Akums Drugs and Pharmaceuticals shares locked in 5 per cent upper circuit at Rs 910.

Meanwhile, at the same time shares of Laurus Lab and Piramal Pharma were trading 3.34 per cent and 2.90 per cent higher respectively.

Durvalumab is employed alone or with other medications to treat adults with various cancers, including biliary tract cancer (such as bile duct and gallbladder cancer), endometrial cancer, hepatocellular carcinoma (liver cancer), non-small cell lung cancer, and small cell lung cancer.